Abstract:Key PointsMuscle wasting is a debilitating condition that develops with ageing and more rapidly with inactivity (bed rest) and in various systemic diseases (for example, cancer, renal failure, chronic obstructive pulmonary disease, sepsis, HIV and trauma). Fibre atrophy primarily results from an acceleration of protein degradation, often combined with reduced protein synthesis. Treatments that prevent this activation of proteolysis or increase protein synthesis offer considerable promise to combat this debilitating process.Various types of rapid muscle wasting develop through a common transcriptional programme involving the induction of a set of atrophy-related genes (atrogenes) by forkhead box protein O (FOXO) transcription factors and reduced signalling by the PI3K–AKT–mTOR pathway.The resulting muscle weakness is a consequence of the degradation of myofibrils, which is catalysed by ubiquitin ligases that target different components of the contractile apparatus for proteasomal degradation. By contrast, the loss of endurance results from the breakdown of mitochondria via autophagy.Myostatin, an autocrine inhibitor of normal muscle growth, and its circulating homologue activin A, also trigger muscle protein loss in various catabolic states via the activation of SMAD2 and SMAD3, which function together with FOXO transcription factors.Antibodies against myostatin or activin A, or agents that block their receptor — activin A receptor, type IIB (ActRIIB) — in muscle could be a promising approach to combat muscle loss caused by cancer-associated cachexia, renal failure and ageing. Indeed, these treatments helped to preserve muscle and prolong longevity in tumour-bearing mice, and several of these treatments are currently in clinical trials.Glucocorticoids and various circulating inflammatory mediators, such as tumour necrosis factor-α (TNFα) and interleukin-6 (IL-6), have also been implicated in excessive muscle proteolysis in cachexia, but their roles in different catabolic states remain uncertain and controversial.Recent studies have increased our understanding of the biochemical mechanisms of atrophy and have identified many intracellular proteins that are crucial in muscle wasting (for example, SMADs, tripartate motif-containing protein 32 (TRIM32), nuclear factor-κB (NF-κB)) or that combat this process (for example, peroxisome proliferator-activated receptor-γ coactivator 1α (PGC1α), sirtuin1 (SIRT1) and JUNB). Their manipulation by small molecules offers many opportunities for the rational design of new treatments for this condition.

Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass

Mechanisms of muscle atrophy and hypertrophy: implications in health and disease

Research Advances in Muscle Stem Cells and Sarcopenia

Cellular and molecular mechanisms of muscle atrophy

Molecular networks in skeletal muscle plasticity

Molecular Basis of Activation and Replenishment on Satellite Cell Shed Light on Myopathy

Muscle wasting in disease: molecular mechanisms and promising therapies

Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models

Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases

Molecular and biochemical regulation of skeletal muscle metabolism

Molecular and Cellular Aspects of Sarcopenia, Muscle Healthy Aging and Physical Conditioning in the Elderly

Evolving Roles of Muscle-Resident Fibro-Adipogenic Progenitors in Health, Regeneration, Neuromuscular Disorders, and Aging

Cellular interactions and microenvironment dynamics in skeletal muscle regeneration and disease

Regulation of Muscle Stem Cell Functions: A Focus on the p38 MAPK Signaling Pathway

From Nutrient to MicroRNA: a Novel Insight into Cell Signaling Involved in Skeletal Muscle Development and Disease.

Integrated Genomic and Proteomic Analyses Identify Stimulus-Dependent Molecular Changes Associated with Distinct Modes of Skeletal Muscle Atrophy

Regulation of muscle stem cells activation: the role of growth factors and extracellular matrix

The inflammatory response, a mixed blessing for muscle homeostasis and plasticity

Molecular and cellular adaptation of muscle in response to physical training

Exercise Protects Proliferative Muscle Satellite Cells Against Exhaustion Via the Igfbp7-Akt-mTOR Axis

Mechanisms of muscle cells alterations and regeneration decline during aging